The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes
Open accessAbstract
The aim of this review was to summarize recent advances in the understanding of the clinical and autoantibody phenotypes, their associated outcomes and the pathogenesis of the juvenile idiopathic inflammatory myopathies ( JIIM s). The major clinical and autoantibody phenotypes in children have many features similar to those in adults, and each has distinct demographic and clinical features and associated outcomes. The most common myositis autoantibodies in JIIM patients are anti‐p155/140, anti‐ MJ and anti‐ MDA 5. Higher mortality has been associated with overlap myositis as well as with the presence of anti‐synthetase and anti‐ MDA 5 autoantibodies; a chronic illness course and lipodystrophy have been associated with anti‐p155/140 autoantibodies; and calcinosis has been associated with anti‐ MJ autoantibodies. Histologic abnormalities of JIIM s detectable on muscle biopsy have also been correlated with myositis‐specific autoantibodies; for example, patients with anti‐ MDA 5 show low levels of inflammatory infiltrate and muscle damage on biopsy. The first genome‐wide association study of adult and juvenile dermatomyositis revealed three novel genetic associations, BLK , PLCL 1 and CCL 21 and confirmed that the human leucocyte antigen region is the primary risk region for juvenile dermatomyositis. Here, we review the well‐established pathogenic processes in JIIM s, including the type 1 interferon and endoplasmic reticulum stress pathways. Several novel JIIM ‐associated inflammatory mediators, such as the innate immune system proteins, myeloid‐related peptide 8/14, galectin 9 and eotaxin, have emerged as promising biomarkers of disease. Advances in our understanding of the phenotypes and pathophysiology of the JIIM s are leading to better tools to help clinicians stratify and treat these heterogeneous disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Special Population of Regulatory T Cells Potentiates Muscle Repair
Burzyn, D., Kuswanto, W., Kolodin, D., Shadrach, J. L., Cerletti, M., Jang, Y., Sefik, E., Tan, T. G., Wagers, A. J., Benoist, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.054 · Cited by 1,234
Cited by
Lundberg, I. E., Tjärnlund, A., Bottai, M., Werth, V. P., Pilkington, C., Visser, M. D., Alfredsson, L., Amato, A. A., Barohn, R. J., Liang, M. H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211468 · Cited by 1,557
Self-citationLundberg, I. E., Tjärnlund, A., Bottai, M., Werth, V. P., Pilkington, C., de Visser, M., Alfredsson, L., Amato, A. A., Barohn, R. J., Liang, M. H., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40320 · Cited by 730
Self-citationKamiya, M., Kimura, N., Umezawa, N., Hasegawa, H., & Yasuda, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1191815 · Cited by 21
Metadata
- Authors
- Rider, L. G., & Nistala, K.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2016-03-30
- Volume
- 280
- Issue
- 1
- Pages
- 24-38
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2322182884
- Cited by
- 168
- References
- 1
- FWCI
- 16.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes. https://app.cochat.ai/papers/10.1111/joim.12444
- The paper
- Rider, L. G., & Nistala, K. (2016). The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes. Journal of Internal Medicine. https://doi.org/10.1111/joim.12444
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.